184 related articles for article (PubMed ID: 16184568)
1. Early hepatic stellate cell activation predicts severe hepatitis C recurrence after liver transplantation.
Gawrieh S; Papouchado BG; Burgart LJ; Kobayashi S; Charlton MR; Gores GJ
Liver Transpl; 2005 Oct; 11(10):1207-13. PubMed ID: 16184568
[TBL] [Abstract][Full Text] [Related]
2. Glial fibrillary acidic protein as an early marker of hepatic stellate cell activation in chronic and posttransplant recurrent hepatitis C.
Carotti S; Morini S; Corradini SG; Burza MA; Molinaro A; Carpino G; Merli M; De Santis A; Muda AO; Rossi M; Attili AF; Gaudio E
Liver Transpl; 2008 Jun; 14(6):806-14. PubMed ID: 18508359
[TBL] [Abstract][Full Text] [Related]
3. Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation.
Carpino G; Morini S; Ginanni Corradini S; Franchitto A; Merli M; Siciliano M; Gentili F; Onetti Muda A; Berloco P; Rossi M; Attili AF; Gaudio E
Dig Liver Dis; 2005 May; 37(5):349-56. PubMed ID: 15843085
[TBL] [Abstract][Full Text] [Related]
4. Hepatic stellate cell activation in liver transplant patients with hepatitis C recurrence and in non-transplanted patients with chronic hepatitis C.
Cisneros L; Londoño MC; Blasco C; Bataller R; Miquel R; Bruguera M; Ginès P; Rimola A
Liver Transpl; 2007 Jul; 13(7):1017-27. PubMed ID: 17600343
[TBL] [Abstract][Full Text] [Related]
5. Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation.
Sreekumar R; Gonzalez-Koch A; Maor-Kendler Y; Batts K; Moreno-Luna L; Poterucha J; Burgart L; Wiesner R; Kremers W; Rosen C; Charlton MR
Hepatology; 2000 Nov; 32(5):1125-30. PubMed ID: 11050065
[TBL] [Abstract][Full Text] [Related]
6. Early hepatic stellate cell activation is associated with advanced fibrosis after liver transplantation in recipients with hepatitis C.
Russo MW; Firpi RJ; Nelson DR; Schoonhoven R; Shrestha R; Fried MW
Liver Transpl; 2005 Oct; 11(10):1235-41. PubMed ID: 16184580
[TBL] [Abstract][Full Text] [Related]
7. A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation.
Yilmaz N; Shiffman ML; Stravitz RT; Sterling RK; Luketic VA; Sanyal AJ; Mills AS; Contos MJ; Coterell A; Maluf D; Posner MP; Fisher RA
Liver Transpl; 2007 Jul; 13(7):975-83. PubMed ID: 17600360
[TBL] [Abstract][Full Text] [Related]
8. Is early recurrence of hepatitis C associated with biliary anastomotic stricture after liver transplantation?
Fujita S; Fujikawa T; Mizuno S; Reed AI; Kim RD; Howard RJ; Firpi RJ; Nelson DR; Hemming AW
Transplantation; 2007 Dec; 84(12):1631-5. PubMed ID: 18165775
[TBL] [Abstract][Full Text] [Related]
9. Patterns of recurrent hepatitis C after liver transplantation in a recent cohort of patients.
Khettry U; Huang WY; Simpson MA; Pomfret EA; Pomposelli JJ; Lewis WD; Jenkins RL; Gordon FD
Hum Pathol; 2007 Mar; 38(3):443-52. PubMed ID: 17188331
[TBL] [Abstract][Full Text] [Related]
10. Hepatic venous pressure gradient to assess fibrosis and its progression after liver transplantation for HCV cirrhosis.
Samonakis DN; Cholongitas E; Thalheimer U; Kalambokis G; Quaglia A; Triantos CK; Mela M; Manousou P; Senzolo M; Dhillon AP; Patch D; Burroughs AK
Liver Transpl; 2007 Sep; 13(9):1305-11. PubMed ID: 17763383
[TBL] [Abstract][Full Text] [Related]
11. Recurrent hepatitis C virus disease after liver transplantation and concurrent biliary tract complications: poor outcome.
Katz LH; Mor E; Brown M; Bar-Nathan N; Shaharabani E; Sulkes J; Pappo O; Tur-Kaspa R; Ben-Ari Z
Clin Transplant; 2006; 20(4):465-70. PubMed ID: 16842523
[TBL] [Abstract][Full Text] [Related]
12. Post-transplant recurrent hepatitis C: immunohistochemical detection of hepatitis C virus core antigen and possible pathogenic implications.
Pessôa MG; Alves VA; Wakamatsu A; Gomes JG; Maertens G; van der Borght B; Kim M; Ferrell L; Wright TL
Liver Int; 2008 Jul; 28(6):807-13. PubMed ID: 18422936
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C recurrence is not associated with allograft steatosis within the first year after liver transplantation.
Machicao VI; Krishna M; Bonatti H; Aqel BA; Nguyen JH; Weigand SD; Rosser BG; Hughes C; Dickson RC
Liver Transpl; 2004 May; 10(5):599-606. PubMed ID: 15108251
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C recurrence is not adversely affected by the use of donation after cardiac death liver allografts.
Tao R; Ruppert K; Cruz RJ; Malik SM; Shaikh O; Ahmad J; DiMartini A; Humar A; Fontes PA; de Vera ME
Liver Transpl; 2010 Nov; 16(11):1288-95. PubMed ID: 21031544
[TBL] [Abstract][Full Text] [Related]
15. HCV histological recurrence and survival following liver transplantation in patients with and without hepatocellular carcinoma.
De Martin E; Senzolo M; Boninsegna S; Guido M; Masier A; Germani G; Tomat S; Brolese A; Neri D; Cillo U; Gambato M; Russo FP; Farinati F; Burra P
Transplant Proc; 2008; 40(6):1974-5. PubMed ID: 18675104
[TBL] [Abstract][Full Text] [Related]
16. Detection of HCV antigens in liver graft: relevance to the management of recurrent post-liver transplant hepatitis C.
Grassi A; Quarneti C; Ravaioli M; Bianchini F; Susca M; D'Errico A; Piscaglia F; Tamè MR; Andreone P; Grazi G; Galli S; Zauli D; Pinna AD; Bianchi FB; Ballardini G
Liver Transpl; 2006 Nov; 12(11):1673-81. PubMed ID: 17031825
[TBL] [Abstract][Full Text] [Related]
17. Hepatic stellate cells in hepatitis C patients: relationship with the development of interstitial fibrosis in renal allografts.
Ozdemir BH; Bilezikçi B; Haberal M
Transplant Proc; 2009 Sep; 41(7):2838-40. PubMed ID: 19765451
[TBL] [Abstract][Full Text] [Related]
18. A 7-gene signature of the recipient predicts the progression of fibrosis after liver transplantation for hepatitis C virus infection.
do O NT; Eurich D; Schmitz P; Schmeding M; Heidenhain C; Bahra M; Trautwein C; Neuhaus P; Neumann UP; Wasmuth HE
Liver Transpl; 2012 Mar; 18(3):298-304. PubMed ID: 22139994
[TBL] [Abstract][Full Text] [Related]
19. Inverse association between hepatic stellate cell apoptosis and fibrosis in chronic hepatitis C virus infection.
Gonzalez SA; Fiel MI; Sauk J; Canchis PW; Liu RC; Chiriboga L; Yee HT; Jacobson IM; Talal AH
J Viral Hepat; 2009 Feb; 16(2):141-8. PubMed ID: 19175868
[TBL] [Abstract][Full Text] [Related]
20. Factors influencing the progression of fibrosis in patients with recurrent hepatitis C after liver transplantation under antiviral therapy: a retrospective analysis of 939 liver biopsies in a single center.
Walter T; Dumortier J; Guillaud O; Hervieu V; Scoazec JY; Boillot O
Liver Transpl; 2007 Feb; 13(2):294-301. PubMed ID: 17256784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
